October Pharma S.A.E

OCPH

EGS380R1C018

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
100 ^EGP	0.00%		0.00%	0.00%

Mar. 10	October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	October Pharma S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

October Pharma S.A.E Announces Financial Results for the Quarter Ended March 31, 2019

May 14, 2019

October Pharma S.A.E announced financial results for the quarter ended March 31, 2019. For the quarter, the company reported Net profit of EGP 3,412,299 against EGP 4,044,433 a year ago.

Latest news about October Pharma S.A.E

October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 10	CI
October Pharma S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-28	CI
October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-28	CI
October Pharma Reports Earnings Results for the Six Months Ended June 30, 2021	21-08-15	CI
October Pharma S.A.E Announces Earnings Results for the Period Ended March 31, 2021	21-06-12	CI
October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-14	CI
October Pharma S.A.E Announces Earnings Results for the Nine Months of 2019 and Full Year 2019	20-02-16	CI
October Pharma S.A.E Announces Earnings Results for the Six Months Ended June 30, 2019	19-08-20	CI
October Pharma Declares Cash Dividend, Payable on July 18, 2019	19-07-02	CI
October Pharma S.A.E Announces Financial Results for the Quarter Ended March 31, 2019	19-05-14	CI
October Pharma Reports Audited Earnings Results for the Year Ended December 31, 2018	19-03-03	CI
October Pharma Announces Earnings Results for the Nine Months Ended September 30, 2018	18-11-13	CI
October Pharma Announces Earnings Results for the Quarter Ended March 31, 2018	18-05-15	CI
October Pharma Declares Cash Dividend, Payable on May 17, 2018	18-05-05	CI
October Pharma Reports Audited Earnings Results for the Year Ended December 31, 2017	18-02-21	CI
October Pharma S.A.E Reports Earnings Results for the Nine Months Ended September 30, 2017	17-11-12	CI
October Pharma Announces Earnings Results for the Six Months Ended June 30, 2017	17-08-13	CI
October Pharma Announces Earnings Results for the Quarter Ended March 31, 2017	17-05-13	CI
October Pharma S.A.E. Declares Cash Dividend, Payable on May 11, 2017	17-04-20	CI
October Pharma Reports Audited Earnings Results for the Year Ended December 31, 2016	17-03-11	CI
October Pharma Announces to Invest EGP 20 Million	15-01-23	CI
October Pharma Announces Earnings Results for the First Six Months of 2014	14-09-17	CI

October Pharma S.A.E. specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of cardiovascular, diabetic, gastroenterological, inflammatory, infectious, metabolic, viral, urological, gynecological, dermatological, dental diseases, etc. At the end of 2020, the group had a production site located in Egypt.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
OCTOBER PHARMA S.A.E	0.00%	25.05M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B